Radiologic tumor border can further stratify prognosis in patients with pancreatic neuroendocrine tumor
- 15 May 2024
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 24 (5) , 753-763
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Science, ICT and Future Planning (2021R1C1C1010138)
This publication has 40 references indexed in Scilit:
- Infiltrative Growth Predicts the Risk of Recurrence After Surgery in Well-Differentiated Non-Functioning Pancreatic Neuroendocrine TumorsEndocrine Pathology, 2022
- Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasmsEuropean Radiology, 2022
- Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsEndocrine Pathology, 2022
- Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CTEuropean Radiology, 2020
- Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumorsDiagnostic and Interventional Imaging, 2018
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017
- Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patientsEuropean Radiology, 2015
- Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumourEuropean Radiology, 2014
- Contrast enhancement pattern on multidetector CT predicts malignancy in pancreatic endocrine tumoursEuropean Radiology, 2014
- Necrosis and Angioinvasion Predict Adverse Outcome in Pancreatic Neuroendocrine Tumors After Curative Surgical Resection: Results of a Single‐Center SeriesWorld Journal of Surgery, 2011